Amanote Research
Register
Sign In
P1.01-75 Utility of cfDNA Testing for Acquired Resistance: The Memorial Sloan Kettering Experience With Plasma EGFR T790M Clinical Testing
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M. Offin
M. Myers
S. Josyula
R. Shen
L. Borsu
D. Tsui
G. Riely
C. Rudin
H. Yu
B. Li
M. Arcila
Publisher
Elsevier BV
Related search
Adult Prostate Sarcoma: The Memorial Sloan Kettering Experience
Urology
Urology
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
JAMA Oncology
Cancer Research
Oncology
Myocarditis Surveillance in Patients With Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience
Oncologist
Cancer Research
Medicine
Oncology
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Molecular Mechanisms of Acquired Resistance to Third-Generation EGFR-TKIs in EGFR T790m-Mutant Lung Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Nasal Metastases From Renal Cell Carcinoma Are Associated With Memorial Sloan-Kettering Cancer Center Poor-Prognosis Classification
Chinese Journal of Cancer
Non-Invasive Urine Testing of EGFR Activating Mutation and T790M Resistance Mutation in Non-Small Cell Lung Cancer
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
P2.03-016 Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Acquired EGFR C797S Mutation Mediates Resistance to AZD9291 in Non–small Cell Lung Cancer Harboring EGFR T790M
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
